There are 2789 resources available
926TiP - Phase II trial of enoblituzumab plus retifanlimab or tebotelimab in first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M SCCHN)
Presenter: Grzegorz Obara
Session: ePoster Display
928TiP - Induction versus adjuvant gemcitabine/cisplatin in locally advanced non-metastatic nasopharyngeal carcinoma: A randomised phase III trial
Presenter: Shereen Masoud
Session: ePoster Display
929TiP - HERODOTUS: Head and neck cancers international COVID-19 collaboration: An international registry on head and neck cancer with COVID-19
Presenter: Amanda Psyrri
Session: ePoster Display
930TiP - innovaTV 207: New dosing cohort in the open label phase II study of tisotumab vedotin in solid tumors
Presenter: David Hong
Session: ePoster Display
931TiP - Malnutrition based on the GLIM criteria and the response to concurrent chemoradiotherapy in patients with squamous cell carcinoma of the head and neck
Presenter: Maria João de Sousa
Session: ePoster Display
933P - Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study
Presenter: Jean-Luc van Laethem
Session: ePoster Display
934P - The TARGET study: A global investigation of advanced dosimetry for transarterial radioembolization of hepatocellular carcinoma with yttrium-90 glass microspheres
Presenter: Marnix Lam
Session: ePoster Display
935P - An exploratory subgroup analysis of a phase II/III trial of donafenib versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma
Presenter: Feng Bi
Session: ePoster Display